Equations match up drugs with your DNA
PENN STATE (US) — Medicines tailored to people based on their genes are becoming a reality, thanks to new statistical models that predict which drug is best for a specific individual with a specific disease.
“Traditional medicine doesn’t consider mechanistic drug response,” says Rongling Wu, director of the Center for Statistical Genetics and professor of public health sciences within the division of biostatistics and bioinformatics at the Penn State College of Medicine.
“We want to look at how an individual person responds to an individual drug by deriving and using sophisticated mathematical models, such as differential equations.”
The current method of prescribing medication now sometimes includes a pharmacogenomic approach, but researchers recognize the limitation of this approach in predicting a response to a particular drug and dosage combination.
Pharmacogenomics, however, uses a person’s genes to explain the difference between how one person responds to a drug compared to another. The team’s equations take this field one step further by also including information about how the body processes a drug and how the drug acts in the body.
Wu focused on the big picture by studying drug response and drug reaction. In particular, the team looked at pharmacokinetics, which influences the concentration of a drug reaching its target, and pharmacodynamics, which determines the drug response. Metabolic, environmental, and developmental factors also play a role in medication response.
The researchers created a statistical analysis framework of differential equations that they expect will help doctors and pharmacists by simulating such variables as protein-protein and protein-DNA interactions a drug has in a patient.
The framework characterizes a drug’s absorption, distribution, and elimination properties, yielding information on pharmacological targets, physiological pathways and, ultimately, disease systems in patients, resulting in predictions of treatment effectiveness.
“The results from this framework will facilitate the quantitative prediction of the responses of individual subjects as well as the design of optimal drug treatments,” the researchers noted in a recent special issue of Advanced Drug Delivery Reviews.
This framework will expand to shed light on the variability of drug response based on information the medical community continues to gather about how an individual responds to a particular drug and dose combination. The information collected is then combined with information about the patient’s genes, proteins and metabolism to help determine what drug and dose might be best for that person.
“If we know how genes control drug response, we can create a statistical model that shows us what will happen before using the drug,” says Wu, who is also a member of Penn State’s Huck Institutes of the Life Sciences. This means a future with more effective medications, faster healing and fewer side effects. “That is our final goal,” Wu says.
Additional researchers from the Center for Statistical Genetics at Penn State, and scientists from the Center for Computational Biology at Beijing Forestry University were involved in the research.
The National Center for Advancing Translational Sciences of the National Institutes of Health supported the study.
Source: Penn State
You are free to share this article under the Creative Commons Attribution-NoDerivs 3.0 Unported license.